Rob Carlson
Managing Director at Planetary Technologies
Seattle, Washington
Overview
Work Experience
Managing Director
2022 - Current
Managing Director
2014
Bioeconomy Capital (BeC) invests in early stage companies with the goal of accelerating the biotechnology revolution. Based on our startup operational expertise, product development experience, and globally recognized strategic analysis, we have developed a blueprint for building and deploying technological capabilities that will become critical infrastructure of the 21st century economy. This proprietary blueprint is the distillation of the fund managers' five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, and Lumen Biosciences.
Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution.
Affiliate Professor
2018
Member Board Of Directors
2013
RoosterBio is a biotechnology company, offers synthetic biology and regenerative medicine.
Raised $40,149,990.00 from Vanedge Capital, Dynamk Capital, Bioeconomy Capital and Dynamk Capital.
Member Board Of Directors
2017
Principal
2005 - 2023
Biodesic is a biological engineering, consulting, and design firm in Seattle and San Francisco. We provide technologies and knowledge to organizations building the future, including design and analysis services for hardware, software, and wetware. We specialize in developing strategy and policy in the context of rapid technological and economic change.
Research Fellow
1997 - 2022
Member, Board of Directors
2012 - 2019
Member, Forum on Synthetic Biology
2013 - 2017
Member, Board of Directors
2013 - 2016
HiveBio is a non-profit organization providing BSL 1 lab and equipment to scientists for research and experiments.